Back to search

University of Patras

Ο ρόλος των ΝΚ κυττάρων στην οξεία μυελογενή λευχαιμία

Abstract

dc:description

Acute myelogenous leukemia (AML) remains a formidable challenge, particularly for patients with recurrent or refractory disease, despite advances in chemotherapy and hematopoietic stem cell transplantation. Current treatments are often associated with severe toxicities and limited long-term success. Innovative cell-based immunotherapies, especially those utilizing natural killer (NK) cells, offer promising new avenues for enhancing therapeutic outcomes. NK cells possess inherent anti-leukemic properties and can be engineered to express chimeric antigen receptors (CARs), potentially boosting their efficacy against AML. In our study, we focused on improving the anti-AML activity and persistence of NK cells by engineering them to express CARs targeting the AML surface antigen CD123, along with interleukin (IL)-15 to enhance their longevity. Detailed in vitro and in vivo analyses revealed that NK cells expressing 2B4.ζ or 4-1BB.ζ signaling domains showed superior anti-AML activity. Notably, 2B4.ζ CAR-NK cells demonstrated enhanced in vivo efficacy compared to untransduced (UTD) and 4-1BB.ζ CAR-NK cells, although this benefit was transient due to limited cell persistence. To address this, we introduced secretory IL-15 (sIL-15) into 2B4.ζ CAR and UTD NK cells, which resulted in improved effector function and a maintained activated NK-cell phenotype during chronic antigen exposure. The transcriptomic analysis supported these findings, highlighting a highly proliferative and activated signature in these modified NK-cell populations. While 2B4.ζ/sIL-15 CAR-NK cells exhibited potent anti-AML activity in one xenograft model, they also induced severe toxicity in another model, underscoring the need for controllable cytokine expression systems. This research paves the way for developing more refined and controllable CAR-NK cell therapies, aiming to maximize therapeutic benefits while minimizing adverse effects, setting the stage for future clinical trials.

Degree

thesis:*
Grantor dc:publisher
University of Patras
Year dc:date
2024

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Christodoulou, Ilias
  • Χριστοδούλου, Ηλίας

Subjects

dc:subject × 12

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/57878

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Christodoulou, Ilias; Χριστοδούλου, Ηλίας. Ο ρόλος των ΝΚ κυττάρων στην οξεία μυελογενή λευχαιμία. University of Patras, 2024. http://hdl.handle.net/10442/hedi/57878